Abstract
Histoscanning is an ultrasound-based computer-assisted technology for tissue differentiation. The technology was developed by Advanced Medical Diagnostics in Belgium.
The first information on histoscanning use comes from a report on the characterization of ovarian masses, but the use of histoscanning for prostate cancer diagnosis was initially published in 2008. Prostate histoscanning (PHS) is designed to distinguish between benign and malignant tissue in solid organs; it uses one compound of ultrasound (US) energy, the backscattered waves (the so-called native radiofrequency data), which is processed using three tissue characterization algorithms.